Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...